Neurocrine Biosciences, Inc.
Status: Publicly traded
Direct answer
Neurocrine Biosciences, Inc. is publicly traded on NASDAQ under the ticker NBIX.
Neurocrine Biosciences, Inc. is a pharmaceutical firm dedicated to the creation, advancement, and commercialization of medicines addressing a spectrum of neurological, endocrine, and psychiatric conditions. Its current therapeutic pipeline and marketed products target disorders such as tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, alongside numerous experimental compounds in various...
Can you invest in Neurocrine Biosciences, Inc.?
Yes. Neurocrine Biosciences, Inc. is publicly traded on NASDAQ under the ticker NBIX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Neurocrine Biosciences, Inc.
Detailed equity research is provided by MarketSnap.